Korean Biotech Startup Targeting Alzheimer’s Treatment Raises $42 Million Round
- Posted on July 16, 2025
- By Forbes
- 2 Views
Korean Biotech Startup Targeting Alzheimer’s Treatment Raises $42 Million Round
Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment.
